Consultant Neurologist #MultipleSclerosis specialist and Senior Lecturer @ImperialCollegeLondon
London, England
Joined February 2011
- Tweets93
- Following148
- Followers131
- Likes99
Dr Antonio Scalfari retweeted
🎙️ New Episode!
Aggressive & Highly Active MS
🧠 BeeWellWithMS Podcast | Dr. Agne Straukiene
with MS expert @AnToSc Dr. Antonio Scalfari
🎧 Listen: beewellwithms.com
📺 Watch: youtu.be/K_O-lYSME3s?si=5n3o…
#MS #multiplesclerosis
Dr Antonio Scalfari retweeted
Some MS patients look stable. But silent damage builds.
With @AnToSc Dr. Scalfari, we dig into what highly active or aggressive MS really means.
🧠 A must-listen for clinicians & patients.
🎧 New BeeWellWithMS episode out soon. #MS #BrainHealth #MultipleSclerosis
Dr Antonio Scalfari retweeted
Clinical manifestations of #SmoulderingMS are often poorly acknowledged. We challenge the
current dogmatic view of #MS, proposing the concept of smouldering associated worsening (#SAW)
@AnToSc @GavinGiovannoni @BagnatoLab @LauraAiras1
Dr Antonio Scalfari retweeted
@AnToSc, of @ImperialNHS, recently highlighted the importance of acknowledging #SmolderingMS, urging a shift in therapeutic focus beyond relapses and advocating for a new approach to disease management. #MulitpleSclerosis #MS
🔗 View the Interview Now: neurologylive.com/view/impor…
Dr Antonio Scalfari retweeted
We recently spoke with @AnToSc, of @ImperialNHS, who talked about a newly published consensus paper focused on smoldering-associated worsening in #MS. Stay tuned for the interview clips on our site! #SmolderingMS
Dr Antonio Scalfari retweeted
Is Smouldering MS the real #MS? On 8 September we hosted a #triMSx webinar that featured five leading HCPs presenting on a range of topics to explore the disease process of smouldering MS.
Take a look at the infographic for a short summary: tinyurl.com/triMSx-Infograph…
Dr Antonio Scalfari retweeted
With some pictures now | extremely good time and high impact science submitted to @aism_nazionale for funding this year | we also took the chance to have some interesting chats and very good food (with @BenedettaBodin1 @paolazaratin @AnToSc @J_SastreGarriga @previste)
Dr Antonio Scalfari retweeted
Did you watch the fourth #triMSx webinar?
This global event discussed 'Smouldering MS: What is it and how to approach it' and featured the latest data, debates and clinical insights.
Why not take a read of the infographic for a short summary: tinyurl.com/triMSx-Infograph…
#MS
Dr Antonio Scalfari retweeted
We are pleased to annouce that Antonio Scalfari @AnToSc will be presenting at the upcoming #triMSx webinar focusing on ageing and smouldering MS.
Register for free here: trimsxwebinar.com/
#triMSx #SmoulderingMS
Dr Antonio Scalfari retweeted
Editor's Pick:
@GavinGiovannoni and colleagues present the concept of smouldering #MultipleSclerosis - a diffuse, continuous pathophysiological process that may affect the whole central nervous system - and its implications for better patient care
journals.sagepub.com/doi/ful…
Dr Antonio Scalfari retweeted
Check out our just published work
A novel prognostic score to assess the risk of progression in relapsing‐remitting multiple sclerosis patients onlinelibrary.wiley.com/doi/…
Great teamwork! @AnToSc
@fr_crescenzo @LabRomualdi @CalabreseMax
Dr Antonio Scalfari retweeted
A novel prognostic score to assess the risk of progression in relapsing‐remitting multiple sclerosis patients
Our work just published
Never forget gray matter damage in #MultipleSclerosis!!!
Well done @pisani_annalisa @AnToSc
onlinelibrary.wiley.com/doi/…
Dr Antonio Scalfari retweeted
Updated safety data on #Ocrelizumab from the patients in the phase III trials : small increase risk of infections. No apparent increase in serious infections or cancer #EAN2019
Dr Antonio Scalfari retweeted
Using Na-MRI we showed that cortical grey matter Na+ accumulation is associated with disability and progression in relapse-onset #MS. A potential novel outcome measure for future neuroprotection trials 🧠 jnnp.bmj.com/content/early/2…
Dr Antonio Scalfari retweeted
A new study shows that there is a limited regeneration of cells in the brain of patients diagnosed with multiple sclerosis (MS). The findings reported in a Nature paper, underline the importance of treating MS at an early stage of the disease progression. go.nature.com/2FMO8yU
Dr Antonio Scalfari retweeted
Progressive #multiplesclerosis
Is driven by.age-related mechanisms
@AnToSc
doi.org/10.1177%2F1352458518…
Dr Antonio Scalfari retweeted
My granddad was an avid nazi until his death in the early 90s. He was a small town banker, volunteered in 40 and became a staff sergeant in the Wehrmacht. He was leading a so called "anti partisan" unit at the Eastern Front, participated in the capture of Kiew.
Dr Antonio Scalfari retweeted
Our new paper out today in #JAMA shows that DMT reduce the risk of conversion to Secondary Progressive MS ja.ma/2FADcmS
Fingolimod, Natalizumab and Alemtuzumab lower this risk more so than platform therapy (HR 0.66)